Caregiver Exclusion in the Age of COVID: Fighting Cancer With Half the Team Blok et al 1 provide sound evidence for a dose-dependent reduction of the risk of contralateral tumors in patients with ...
Treatment of poor-risk non seminomatous germ-cell tumors (NSGCT) adapted by tumor marker decline: A 7-year multicenter real-world experience. This is an ASCO Meeting Abstract from the 2025 ASCO Annual ...
Surveillance plays a major role in the management of men with cancer clinically confined to the testis. Both the American Urological Association (AUA) and the European Association of Urology (EAU) ...
Non-seminoma is a type of germ-cell testicular cancer. Treatment may include surgery to remove a testicle, lymph node removal, and chemotherapy. Most cases of testicular cancer develop from germ cells ...
Please provide your email address to receive an email when new articles are posted on . De-escalation of treatment after two cycles of chemotherapy and a negative PET scan appeared safe and feasible ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results